Multiple Sclerosis (MS) is a lifelong autoimmune condition that affects the brain and the spinal cord, resulting in a wide range of symptoms that vary from person-to-person.
Depending on the severity, MS can be debilitating, leading to problems with vision, balance and movement.
While there is no cure, the disease can be treated and managed with various medications.
Joan Didion, Jack Osbourne and Selma Blair, who was diagnosed in August 2018, are among those in the public eye who live with MS.
The NHS estimates there to be 100,000 people with the condition in the UK.
Oxford Biodynamics PLC (LON:OBD) was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer and other diseases including ALS.